Associated Papers
A systematic review and meta-analysis of GFAP gene variants in Alexander disease.
Grossi A et al.
Scientific Reports, 2024
39420046 (PubMed )
Supplement: 41598_2024_75383_MOESM2_ESM.xlsx › Suppl._Table_2
Glial fibrillary acidic protein is pathologically modified in Alexander disease.
Lin NH et al.
The Journal of Biological Chemistry, 2024
A report of two cases of bulbospinal form Alexander disease and preliminary exploration of the disease.
Song X et al.
Molecular Medicine Reports, 2021
Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
Battaglia RA et al.
Elife, 2019
Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.
Lin NH et al.
Plos One, 2017
Astrocytic TDP-43 pathology in Alexander disease.
Walker AK et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2014
Archetypal and new families with Alexander disease and novel mutations in GFAP.
Messing A et al.
Archives of Neurology, 2012
Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival.
Hagemann TL et al.
Plos One, 2012
Select a paper to view details